Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus

Recruiting

Phase 2

OPT101Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus

Sponsor:

Op-T LLC

Code:

NCT06964087

Conditions

Type I Diabetes

Eligibility Criteria

Sex: All

Age: 18 - 50

Healthy Volunteers: Not accepted

Interventions

OPT101

OPT101 Placebo to Match (PTM)

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-07-06. This information was provided to ClinicalTrials.gov by Op-T LLC on 2026-04-06.